Tenormin LS 50mg tablets

Երկիր: Միացյալ Թագավորություն

Լեզու: անգլերեն

Աղբյուրը: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ակտիվ բաղադրիչ:

Atenolol

Հասանելի է:

Waymade Healthcare Plc

ATC կոդը:

C07AB03

INN (Միջազգային անվանումը):

Atenolol

Դոզան:

50mg

Դեղագործական ձեւ:

Oral tablet

Կառավարման երթուղին:

Oral

Դաս:

No Controlled Drug Status

Ռեկվիզորի տեսակը:

Valid as a prescribable product

Ապրանքի ամփոփագիր:

BNF: 02040000

Տեղեկատվական թերթիկ

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
TENORMIN® LS 50 MG TABLETS
(atenolol)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
•
Keep this leaflet. You may need to read it again.
•
If you have any further questions, ask your doctor or pharmacist.
•
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even if their signs of illness are the same
as
yours.
•
If you get any side effects, talk to your doctor or pharmacist.
This includes any possible side effects not listed in this leaflet.
See
section 4.
The name of your medicine is Tenormin LS 50mg Tablets but will be
referred to as Tenormin throughout the remainder of the leaflet.
WHAT IS IN THIS LEAFLET:
1. What Tenormin is and what it is used for
2. What you need to know before you take Tenormin
3. How to take Tenormin
4. Possible side effects
5. How to store Tenormin
6. Contents of the pack and other information
1. WHAT TENORMIN IS AND WHAT IT IS USED FOR
Tenormin contains a medicine called atenolol. This belongs to a group
of
medicines called beta-blockers. Tenormin is used to:
•
Treat high blood pressure (hypertension).
•
Treat uneven heart beats (arrhythmias).
•
Help prevent chest pain (angina).
•
Protect the heart in the early treatment after a heart attack
(myocardial
infarction).
It works by making your heart beat more slowly and with less force.
2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TENORMIN
DO NOT TAKE TENORMIN:
•
If you are allergic to atenolol or any of the other ingredients of
this
medicine (listed in section 6).
•
If you have ever had any of the following heart problems:
−
heart failure which is not under control (this usually makes you
breathless and causes your ankles to swell)
−
second – or third-degree heart block (a condition which may be
treated by a pacemaker)
−
very slow or very uneven heart beats, very low blood pressure or
very poor circulation.
•
If you have a tumour called phaeochromocy

Ապրանքի հատկությունները

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
‘Tenormin’ LS 50mg tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Atenolol 50 mg.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Film-coated tablet.
White, round, biconvex, film-coated tablets of diameter 8 mm, which
are intagliated with 50
on one face and bisected on the reverse face.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Tenormin is indicated in the treatment of:
•
Management of hypertension.
•
Management of angina pectoris.
•
Management of cardiac arrhythmias.
•
Management of myocardial infarction. Early intervention in the acute
phase.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
POSOLOGY
The dose must always be adjusted to individual requirements of the
patients, with the lowest possible starting dosage. The following are
guidelines:
ADULTS
HYPERTENSION
One tablet daily. Most patients respond to 100 mg daily given orally
as a
single dose. Some patients, however, will respond to 50 mg given as a
single daily dose. The effect will be fully established after one to
two
weeks. A further reduction in blood pressure may be achieved by
combining Tenormin with other antihypertensive agents. For example,
co-
administration of Tenormin with a diuretic, as in Tenoretic provides a
highly effective and convenient antihypertensive therapy.
ANGINA
Most patients with angina pectoris will respond to 100 mg given orally
once
daily or 50 mg given twice daily. It is unlikely that additional
benefit will
be gained by increasing the dose.
CARDIAC ARRHYTHMIAS
A suitable initial dose of Tenormin is 2.5 mg (5 ml) injected
intravenously
over a 2.5 minute period (i.e. 1 mg/minute). (See also prescribing
information for Tenormin Injection.) This may be repeated at 5 minute
intervals, until a response is observed up to a maximum dosage of 10
mg. If
Tenormin is given by infusion, 0.15 mg/kg bodyweight may be
administered over a 20 minute period. If required, the injection or
infusion
may be repeated every 12 hours. Having